Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLA1A | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
mRNA | CTDSPL2 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | LEPROT | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | NUCKS1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | SLIT3 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-07 |
mRNA | ORC2 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | COX7A1 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
mRNA | MRPL50 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | SULF1 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
mRNA | IPO9 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |